U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of about $30 billion, a person familiar with the matter said on Monday. The company could announce the separation of the business,

Medical device maker Becton Dickinson & Co. is considering a potential separation of its life sciences segment, which could be valued at about $30 billion, according to people familiar with the matter.